They establish a local immunosuppressive microenvironment by secreting mediators like TGF-β, IL-10, and arginase, which not only protect the graft from effector cell attack but also severely weaken antitumor immune surveillance, creating favorable conditions for tumor recurrence [35,36,37]. Here, TGFB1 is linked to neoplasm.